Introduction {#s0001}
============

The number of patients with chronic kidney disease (CKD) as well as those with end-stage renal disease (ESRD) is on the rise worldwide. Under the new updated guidance of National Kidney Foundation (NKF)/Dialysis Out-comes Quality Initiative (DOQI) guidelines \[[@CIT0001]\]. Arteriovenous fistula (AVF) is the most preferred choice for chronic hemodialysis (HD) among the three main types of access \[i.e., AVF, arteriovenous graft, and central venous catheter (CVC)\]. Meanwhile, there are a number of researchers reported the diabetes mellitus may be associated with arteriovenous fistula failure, and the effects of diabetes on overall AVF outcomes may be minimized by careful preoperative vessel imaging and AVF site selection. Therefore, this review was aimed to find out whether diabetes was related with AVF failure by meta-analysis.

Methods {#s0002}
=======

This systematic review and meta-analysis were conducted according to the Preferred Reporting Items for Systematic Review and Meta-Analysis (PRISMA) guidelines \[[@CIT0002]\].

**Search strategy.** We performed an online search published in English and Chinese using the electronic databases MEDLINE, SCIENCE DIRECT, SPRINGER, WILEY-BLACKWELL, KARGER, EMbase, CNKI and WanFang Data by the University library resource discovery system for relevant retrospective studies and prospective studies up to January 2016. The keyword combination is '((arteriovenous fistula failure) OR arteriovenous fistula thrombosis) AND diabetes mellitus'. After obtaining the results, 553 (388 Chinese, 165 English respectively) abstracts of the relevant titles had been read online, 69 relevant articles (53 English, 16 Chinese) were checked by full text. The references of the identified articles were resolved as well. Eventually, we selected 120 articles and read through ([Figure 1](#F0001){ref-type="fig"}).

![Study flow diagram of the meta-analysis.](IRNF_A_1456464_F0001_B){#F0001}

**Selection criteria.** (1) We included studies concerning risk factors for arteriovenous fistula failure in dialysis patients up to January 2016; (2) research methods: retrospective and prospective studies; (3) the definition of exposure factor is similar and no difference of diagnostic criteria of AVF failure and diabetes; (4) there was no restriction with regard to publication status; language was confined to English and Chinese; (5) there were control group and diabetic group.

**Exclusion criteria.** (1) Repeated reports, poor quality, little information or absent data; (2) inconsistent definitions and included confounding factors. (3) Different diagnosis criteria, animal experiments and qualitative research. (4) Review articles and case reports would be excluded from the analysis.

**About definitions.** Diabetes mellitus was considered to be present if the patient was on a diabetic diet, current use of hypoglycemic medication, use of insulin or when the diagnosis was recorded in a medical status, or if the fasting plasma glucose exceeded 140 mg/dl. AVF failure was defined as primary non-function due to thrombosis (before puncturing) or non-maturation \[[@CIT0003]\]. Vascular access thrombosis (VAT) was defined as a lack of blood flow diagnosed by palpation and auscultation. The presence of thrombus was confirmed by surgery or angiography.

Twenty-three relevant studies were identified using the above criteria and included in the final analysis ([Table 1](#t0001){ref-type="table"}) \[[@CIT0003]\]. The types of research used in the meta-analysis included retrospective and prospective studies; as expected, there was not any randomized controlled trial. The prespecified study end points were thrombosis or failure to mature resulting in inadequate functioning.

###### 

Twenty-three Studies included in qualitative synthesis.

  study                        year   race        tevent   tnoevent   ttotal   cevent   cnoevent   ctotal   sum
  ---------------------------- ------ ----------- -------- ---------- -------- -------- ---------- -------- -----
  Shen B                       2006   Asian       4        11         15       2        23         25       40
  Zhang ZM                     2007   Asian       18       58         76       57       303        360      436
  Liao YL                      2015   Asian       10       13         23       21       74         95       118
  Jiang Y                      2013   Asian       7        25         32       11       29         40       72
  Hu DJ                        2014   Asian       14       20         34       6        28         34       68
  Zhang YL                     2010   Asian       12       20         32       56       154        210      242
  Baris Afsar Rengin Elsurer   2012   Caucasian   30       44         74       43       116        159      233
  Najiba Fekih-Mrissa          2011   Caucasian   9        19         28       17       33         50       78
  Jamshid Roozbeh              2005   Caucasian   16       15         31       68       72         140      171
  Ju-Young Moon                2015   Asian       70       39         109      230      139        369      478
  BRANED J.MANNS               1998   Caucasian   9        18         27       23       39         62       89
  DOUGLAS SHEMIN               1999   Caucasian   28       19         47       15       22         37       84
  A.Bahadi                     2012   Caucasian   14       19         33       32       73         105      138
  Engin Usta                   2012   Caucasian   11       7          18       41       21         62       80
  Yao SL 2015                  2015   Asian       13       18         31       43       141        184      215
  Li ZZ 2014                   2014   Asian       28       45         73       30       106        136      209
  Wang YZ                      2005   Asian       9        13         22       6        30         36       58
  Zhong HY                     2010   Asian       10       13         23       22       83         105      128
  Chen MX11                    2015   Asian       8        18         26       24       137        161      187
  Wei XH                       2015   Asian       6        15         21       22       53         75       96
  Cui TL                       2012   Asian       33       30         63       68       135        203      266
  He Q                         2009   Asian       9        25         34       35       280        315      349
  Ramazan Danis                2009   Caucasian   17       41         58       29       145        174      232

**Statistical analysis.** Data were extracted from the studies and recorded into [Table 1](#t0001){ref-type="table"}. AVF failure was transformed into a dichotomous outcome. Data extraction was done from tables, texts, or graphs from relevant sources. Statistical analysis was performed using STATA 12.0 software and Review Manager 5.3 software.

**Forest plot**: The odds ratio (OR) was used to present effects in a logarithmic scale in the analysis. An OR \>1 indicated higher risk in diabetes patients, whereas an OR \<1 indicated higher risk in non-diabetes patients. The 95% confidence interval (CI) describes the possible range that the pooled OR could take; any CI that included 1 (the point of equal effect of the two groups) was considered not to be statistically significant. In the analysis, the line of identity is 1 and the CI is significant if it does not cross 1. The OR and 95% CI for combined studies were calculated using the M-H heterogeneity model of meta-analysis. The presence of heterogeneity was assessed using the I^2^ statistic.

**Funnel plot:** (1) Use effects estimated value as the abscissa and sample size as the ordinate to draw a scatter plot. According to the degree of asymmetric graphics to judge whether there are bias or not in the meta analysis; (2) based on the fact that the accuracy of the effects is proportional to the sample size. In the analysis, a funnel plot for all studies was included to assess the degree of publication bias, any asymmetry around the vertical axis indicated the presence of such bias.

Results {#s0003}
=======

Twenty-three studies were used in the analysis, which included a total of 930 diabetic patients and 3137 nondiabetic patients with end-stage renal disease. AVF failure was reported in all studies ([Table 1](#t0001){ref-type="table"}). The pooled OR estimate for the AVF failure was 1.682 (95% CI, 1.429--1.981, Test of OR = 1: z = 6.25, *p* \< .001) in favor of the diabetic patients ([Figure 2](#F0002){ref-type="fig"}). These results revealed a statistically significantly higher rate of AVF failure in diabetic patients compared with nondiabetic patients.
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A funnel plot shows publication bias of the studies, as seen from the [Figure 3](#F0003){ref-type="fig"}, the plot was over-all symmetrical, which indicates little publication bias. The Begg's test and Egger's test were also used to check publication bias quantitatively. Begg's test *p* = .526 \> .05 ([Figure 4](#F0004){ref-type="fig"}) and Egger's test *p* = .408 \> .05 ([Figure 5](#F0005){ref-type="fig"}), implies little publication bias. As shown in the [Figure 2](#F0002){ref-type="fig"}, there was almost non-heterogeneous between the studies (I^2^=9.7%; [Figure 2](#F0002){ref-type="fig"}).
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Discussion {#s0004}
==========

AVF is the main permanent vascular access for hemodialysis and a lifeline for patients who need hemodialysis. Mature AVF provides adequate blood flow and long working time for hemodialysis with few complications and has become the ideal vascular access for patients receiving hemodialysis. But, AVF dysfunction is still the primary problem bothering doctors and patients.

As the changes of the primary disease, the number of diabetic patients is on the rise. Besides, the presence of diabetes is apt to diabetic nephropathy, which commonly needs a hemodialysis therapy at the end \[[@CIT0026]\]. The results from the meta-analysis study indicate that diabetes patients are more likely to cause AVF failure. Although the mechanism is not clear yet, the following may provide a possible explanation. Diabetes causes a high risk of platelet aggregation and increases release of von Willebrand factor, which promotes the platelet aggregation and results in damaging to endothelial cells in blood vessels \[[@CIT0027]\]. The pathophysiological mechanism of diabetes leads to the formation of thrombosis more easily. If vascular intima damage and angiosclerosis exist simultaneously, thrombosis formation becomes extremely easily. Basic research proves that the blood vessel walls have both the antithrombotic and prothrombotic factors the ultimate consequences after vascular injury depends on the balance of the two sides. Besides, hyperglycemia and the increasing of glycosylation end products bring about a series of bioactive substances disorders, making it liable to injure to the internal wall of vessels and blood vessels become less elastic, thereby leading to blood flow retardation and platelet aggregation, and ultimately thrombosis.

On account of atherosclerosis exists more often and severe in diabetes patients, there is a wide range of vascular lesions, making it difficult to establish a vascular access \[[@CIT0028]\]. In addition, diabetes is often accompanied by hyperlipemia, hypoalbuminemia, and high blood coagulation, which also lead to AVF's obstruction. beyond that, diabetic patients prone to lipid deposition, especially in vascular wall near anastomotic stoma, causing dysplasia of blood clots or postoperative fistula more easily. Due to hemodynamics effects, the vein which near anastomotic stoma is struck by blood flow, leading to inner membrane injury, platelets and fiberdeposition, causing vascular intimal hyperplasia and stenosis.

Some studies indicated atherosclerotic changes in forearm arteries in diabetic patients appear in 60% of hemodialysis patients \[[@CIT0028]\]. It is possible to create a native AVF in 90% of diabetic patients, although this requires more procedures. However, it is difficult to create an AVF only in the remaining 10% of diabetic patients. In patients with diabetes, AVF in the wrist region should be preferred \[[@CIT0028]\]. In case of fistula failure, revision is a reliable procedure salvaging a failed fistula, which yields an acceptable patency rate of regardless of the patient's risk factors for arteriosclerosis \[[@CIT0029]\].

In order to make AVF work longer, following precautionary measures should be taken: (1) blood glucose control; (2) weight control, adjust blood lipid metabolism; (3) strengthen the fistula in exercise after establishing fistulas \[[@CIT0030]\]; (4) timing monitoring vascular access, improve the rate of nutritional status, diabetes control; (5) recommend peritoneal dialysis in diabetes patients.
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